![Stephen DiPalma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen DiPalma
Directeur/Membre du Conseil chez
Phytera, Inc.
Profil
Stephen J.
DiPalma is the founder of Blueprint Genetics, Inc. (founded in 1988) and Catalyst Oncology, Inc. (founded in 2004).
He held the title of Chief Financial Officer at Blueprint Genetics, Inc. from 1988 to 1995 and the title of President & Chief Executive Officer at Catalyst Oncology, Inc. Mr. DiPalma's current job(s) included being a Director at Phytera, Inc. since 1998 and a Co-Managing Director at Danforth Advisors LLC since 2014.
Mr. DiPalma's former job(s) include being a Director at Cognoptix, Inc., Chief Financial Officer at Aquila Biopharmaceuticals, Inc., Chief Financial Officer at Interleukin Genetics, Inc. from 2014 to 2017, Chief Financial Officer & Senior Vice President at FORUM Pharmaceuticals, Inc. from 2009 to 2014, Chief Financial Officer at Histogenics Corp.
in 2015, Chief Financial Officer & EVP-Business Operations at Galena Biopharma, Inc. in 2009, Chief Financial Officer at Scorpius Holdings, Inc., Chief Financial Officer at Anchiano Therapeutics Ltd. in 2020, Chief Financial Officer at Milkhaus Laboratory, Inc. from 2002 to 2004, Divisional Controller at The Health Data Institute, Inc., Chief Financial Officer & Treasurer at Spero Therapeutics, Inc. from 2019 to 2021, Chief Financial Officer & Treasurer at Spero Therapeutics, Inc. in 2023, Chief Financial & Accounting Officer at Beyond Air, Inc. in 2018, Treasurer, Chief Financial & Accounting Officer at Solid Biosciences, Inc. from 2021 to 2023, Chief Financial & Accounting Officer at Inozyme Pharma, Inc., Chief Financial & Accounting Officer at Generation Bio Co. from 2019 to 2020, Chief Financial Officer at LAVA Therapeutics NV, Chief Financial Officer at CG Oncology, Inc., and Chief Financial Officer & Treasurer at Foghorn Therapeutics, Inc. in 2024.
Mr. DiPalma's education history includes an MBA from Babson College in 1988 and an undergraduate degree from the University of Massachusetts Lowell.
Postes actifs de Stephen DiPalma
| Sociétés | Poste | Début |
|---|---|---|
Phytera, Inc.
 Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals | Directeur/Membre du Conseil | 01/01/1998 |
Danforth Advisors LLC
 Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Corporate Officer/Principal | 01/04/2014 |
Anciens postes connus de Stephen DiPalma
| Sociétés | Poste | Fin |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Directeur Financier/CFO | 16/04/2024 |
| SPERO THERAPEUTICS, INC. | Directeur Financier/CFO | 06/11/2023 |
| SOLID BIOSCIENCES INC. | Directeur Financier/CFO | 09/01/2023 |
| LAVA THERAPEUTICS N.V. | Directeur Financier/CFO | 15/03/2021 |
| SPERO THERAPEUTICS, INC. | Directeur Financier/CFO | 04/01/2021 |
Formation de Stephen DiPalma
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Aquila Biopharmaceuticals, Inc.
 Aquila Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops and makes products for the diagnosis, prevention and treatment of infectious diseases | Health Technology |
Phytera, Inc.
Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals | Commercial Services |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops personalized health products | Health Technology |
Blueprint Genetics, Inc.
 Blueprint Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical diagnostics testing laboratory services | Commercial Services |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Cognoptix, Inc.
 Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease | Health Services |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Health Technology |
Scorpius Holdings, Inc.
 Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Milkhaus Laboratory, Inc.
 Milkhaus Laboratory, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures organic chemical products | Process Industries |
Catalyst Oncology, Inc.
 Catalyst Oncology, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic tests for breast, colon and potentially other cancers | Health Services |
The Health Data Institute, Inc. | |
University of Massachusetts Lowell
 University of Massachusetts Lowell Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Commercial Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Beyond Air, Inc.
 Beyond Air, Inc. Medical SpecialtiesHealth Technology Developing a platform of nitric oxide generators and delivery systems | Health Technology |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
LAVA Therapeutics NV
 LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
